0001493152-23-040175.txt : 20231109
0001493152-23-040175.hdr.sgml : 20231109
20231109195553
ACCESSION NUMBER: 0001493152-23-040175
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221107
FILED AS OF DATE: 20231109
DATE AS OF CHANGE: 20231109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bui Lynne A.
CENTRAL INDEX KEY: 0001903698
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41210
FILM NUMBER: 231394283
MAIL ADDRESS:
STREET 1: 1200 ROUTE 22 EAST
STREET 2: SUITE 2000
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tharimmune, Inc.
CENTRAL INDEX KEY: 0001861657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 842642541
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 ROUTE 22 EAST
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 302-743-2995
MAIL ADDRESS:
STREET 1: 245 MAIN STREET
STREET 2: SUITE 204
CITY: CHESTER
STATE: NJ
ZIP: 07930
FORMER COMPANY:
FORMER CONFORMED NAME: Tharimmune, Inc
DATE OF NAME CHANGE: 20230925
FORMER COMPANY:
FORMER CONFORMED NAME: Hillstream BioPharma Inc.
DATE OF NAME CHANGE: 20210511
4
1
ownership.xml
X0508
4
2022-11-07
0
0001861657
Tharimmune, Inc.
THAR
0001903698
Bui Lynne A.
C/O THARIMMUNE, INC.
1200 ROUTE 22 EAST, SUITE 2000
BRIDGEWATER
NJ
08807
1
0
0
0
0
Options (right to buy)
0.1577
2023-11-07
4
A
0
25000
0
A
2033-11-07
Common stock
25000
25000
D
On November 7, 2023, the Reporting Person was granted options ("Options") to purchase up to 25,000 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.
/s/ Randy Milby as Attorney-In-Fact for Lynne Bui
2023-11-09